Valuation Genomma Lab Internacional, S.A.B. de C.V.

Stocks

End-of-day quote Mexican S.E. 2026-09-04			5-day change	1st Jan Change
13.01 ^MXN	-0.54%		-3.63%	-27.28%

08-31	Genomma Lab Internacional, S.A.B. de C.V. Enters Into MXN 1.0 Billion Long-Term Credit Facility With Banamex	CI
07-23	Genomma Lab Internacional, S.A.B. de C.V., Q2 2026 Earnings Call, Jul 23, 2026

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	21,614	16,849	13,161	23,244	17,474	12,685	-	-
Change	-	-22.05%	-21.89%	76.61%	-24.82%	-27.4%	-	-
Enterprise Value (EV) ¹	26,264	21,719	17,681	27,294	22,241	17,138	16,244	15,522
Change	-	-17.3%	-18.59%	54.37%	-18.51%	-22.94%	-5.22%	-4.44%
P/E	14.9x	12x	13.1x	11.7x	11.1x	5.08x	6.1x	5.36x
PBR	1.96x	1.75x	1.44x	2.26x	1.57x	0.9x	-	-
PEG	-	-5.76x	-0.6x	0.1x	-0.4x	0.1x	-0.4x	0.4x
Capitalization / Revenue	1.4x	1x	0.8x	1.25x	1x	0.68x	0.66x	0.62x
EV / Revenue	1.7x	1.29x	1.07x	1.47x	1.27x	0.92x	0.85x	0.76x
EV / EBITDA	8.18x	6.26x	5.12x	6.3x	5.42x	3.76x	3.65x	3.26x
EV / EBIT	8.57x	6.66x	5.48x	6.85x	5.92x	4.08x	4.01x	3.59x
EV / FCF	32.1x	13.4x	8.81x	9.77x	14.8x	15.5x	7.8x	6.74x
FCF Yield	3.11%	7.49%	11.4%	10.2%	6.77%	6.46%	12.8%	14.8%
Dividend per Share ²	0.3817	0.3817	0.1961	0.8	0.8	0.8342	1.232	1.585
Rate of return	1.78%	2.25%	1.38%	3.18%	4.47%	6.41%	9.47%	12.2%
EPS ²	1.44	1.41	1.08	2.14	1.61	2.56	2.132	2.425
Distribution rate	26.5%	27.1%	18.2%	37.4%	49.7%	32.6%	57.8%	65.4%
Net sales ¹	15,460	16,859	16,467	18,607	17,541	18,724	19,192	20,340
EBITDA ¹	3,210	3,471	3,454	4,330	4,101	4,558	4,448	4,764
EBIT ¹	3,063	3,263	3,224	3,982	3,760	4,198	4,052	4,330
Net income ¹	1,451	1,397	1,031	2,137	1,607	2,194	2,177	2,457
Net Debt ¹	4,650	4,870	4,520	4,050	4,768	4,453	3,559	2,837
Reference price ²	21.48	16.94	14.16	25.13	17.89	13.01	13.01	13.01
Nbr of stocks (in thousands)	1,006,240	994,639	929,461	924,946	976,728	975,033	-	-
Announcement Date	2/23/22	2/22/23	2/21/24	2/26/25	2/25/26	-	-	-

¹MXN in Million²MXN

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.	5.08x	0.92x	3.76x	6.41%	752M
ELI LILLY AND COMPANY	32.72x	11.9x	24.26x	0.6%	1,024B
JOHNSON & JOHNSON	30.62x	-	-	1.95%	663B
ABBVIE INC.	32.73x	7.6x	15.8x	2.67%	453B
ROCHE HOLDING AG	19.89x	4.73x	11.71x	2.8%	352B
NOVARTIS AG	22.72x	5.84x	14.51x	2.7%	304B
ASTRAZENECA PLC	20.87x	4.29x	12.24x	2.06%	252B
AMGEN INC.	27.66x	7.14x	13.15x	2.31%	236B
NOVO NORDISK A/S	13.33x	4.82x	10.06x	3.78%	206B
GILEAD SCIENCES, INC.	-46.14x	6.65x	25.95x	2.18%	187B
Average	15.95x	5.99x	14.61x	2.75%	367.91B
Weighted average by Cap.	24.05x	7.99x	17.80x	1.95%